Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer
Crossref DOI link: https://doi.org/10.1186/s12955-016-0449-z
Published Online: 2016-03-25
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Smyth, Emily Nash https://orcid.org/0000-0003-0583-0882
Shen, Wei
Bowman, Lee
Peterson, Patrick
John, William
Melemed, Allen
Liepa, Astra M.
Funding for this research was provided by:
Eli Lilly and Company (US)